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kd determinationA great number of membrane proteins have proven difﬁcult to crystallise for use in X-ray crystallographic
structural determination or too complex for NMR structural studies. Circular dichroism (CD) is a fast and rel-
atively easy spectroscopic technique to study protein conformational behaviour. In this review examples of
the applications of CD and synchrotron radiation CD (SRCD) to membrane protein ligand binding interaction
studies are discussed. The availability of SRCD has been an important advancement in recent progress, most
particularly because it can be used to extend the spectral region in the far-UV region (important for increas-
ing the accuracy of secondary structure estimations) and for working with membrane proteins available in
only small quantities for which SRCD has facilitated molecular recognition studies. Such studies have been
accomplished by probing in the near-UV region the local tertiary structure of aromatic amino acid residues
upon addition of chiral or non-chiral ligands using long pathlength cells of small volume capacity. In partic-
ular, this review describes the most recent use of the technique in the following areas: to obtain quantitative
data on ligand binding (exempliﬁed by the FsrC membrane sensor kinase receptor); to distinguish between
functionally similar drugs that exhibit different mechanisms of action towards membrane proteins (exempli-
ﬁed by secretory phospholipase A2); and to identify suitable detergent conditions to observe membrane
protein–ligand interactions using stabilised proteins (exempliﬁed by the antiseptic transporter SugE). Finally,
the importance of characterising in solution the conformational behaviour and ligand binding properties of
proteins in both far- and near-UV regions is discussed. This article is part of a Special Issue entitled: Structural
and biophysical characterisation of membrane protein–ligand binding.
© 2013 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2. Quantitative data on membrane protein–ligand binding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3. Identiﬁcation of functionally similar but mechanistically distinct drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4. Effects of environment conditions (detergents/surfactants, reducing agents, salt ionic strength and ligands) to observe membrane
protein–ligand interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
5. Summary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41
5
39, synchrotron radiation circular dichroism; CD, circular dichroism; GBAP, gelatinase biosynthesis-activating pheromone; UV,
constant; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
ural and biophysical characterisation of membrane protein–ligand binding.
rwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, UK. Tel.: +44 1235 778425.
G. Siligardi), rohanah.hussain@diamond.ac.uk (R. Hussain), s.g.patching@leeds.ac.uk (S.G. Patching),
l rights reserved.
35G. Siligardi et al. / Biochimica et Biophysica Acta 1838 (2014) 34–421. Introduction
Circular dichroism (CD) is a well-known spectroscopic technique
to study chiral molecules, in particular proteins in solution as well
as in thin amorphous dry ﬁlms [1–4]. Through pattern recognition
of the CD spectral features, proteins can be classiﬁed in terms of
their folding and secondary structure composition. A unique strength
of CD spectroscopy is its high sensitivity to sample perturbations
allowing proteins to be investigated qualitatively and quantitatively
as a function of temperature, solvent composition, chemical agents,
detergents, pH, and ligand binding interactions [5–9]. SRCDmeasured
at Diamond B23 beamline shares the same advantage of other SRCD
beamlines worldwide, by having higher photon ﬂux and extended
vacuum UV region down to 125 nm. This is the technique of choice
for the characterisation of membrane protein property in solution.
SRCD spectra measured at Diamond B23 beamline provide additional
information content than those from bench-top CD instruments be-
cause of the beamline's higher photon ﬂux and extended vacuum
UV region down to 125 nm [8,11,12]. Also a unique feature of B23 is
its highly collimated and small cross section beam light that allows
measurements using very small volume capacity cells of a wide
range of pathlengths, from a few microns to 10 cm [8,11,12] other-
wise unattainable with bench-top instruments.
CD spectroscopy has proved highly useful for studies of ligand
binding by soluble proteins [5–12], particularly as it is a relatively
quick and easy spectroscopic measurement, requiring no extensive
sample preparation, and it has the potential for use in rapid through-
put technologies [13]. However, there have been fewer examples of
its use in studies of ligand and/or drug binding to membrane proteins
(see Section 2). CD and SRCD have most frequently been used to de-
termine secondary structural content and integrity of membrane pro-
teins such as histidine kinases [14–17], membrane transport proteins
[18], protein fragments [19] and in membrane unfolding studies
[16,18]. Sreerama and Woody [20] found that the CD analysis of sec-
ondary structure content of membrane proteins using soluble protein
reference sets was slightly inferior to that obtained for soluble pro-
teins. The inclusion of membrane proteins in the soluble protein ref-
erence sets – now common practise – has since improved the CD
analysis for both membrane and soluble proteins [21–23]. It is not
our intention here to provide a detailed review of all these aspects,
but rather to describe recent developing advances in CD- and
SRCD-based approaches that offer promising routes for progressing
knowledge of membrane protein–ligand interactions in the future.
Perhaps the main reason why the application of CD and SRCD
spectroscopy methods has proved more limited for ligand binding
studies of membrane proteins in the past is largely due to the techni-
cal challenges associated with working with hydrophobic membrane
proteins. Here we review some examples of the very recent advances
in the use of CD and SRCD spectroscopy for qualitative and quantita-
tive ligand- and drug-binding interactions by membrane proteins. A
number of technical but addressable considerations have also been
reported in these studies; they address some of the technical chal-
lenges, and have resulted in the successful use of the techniques for:
(i) obtaining quantitative data on ligand and inhibitor binding to
membrane proteins (FsrC) [24,25], (ii) identifying functionally simi-
lar but mechanistically distinct drugs that target membrane proteins
(PLA2) [26]; and (iii) characterising suitable detergent conditions
for observing ligand interactions in membrane proteins [27–33]. A
more detailed account is now described.
2. Quantitative data on membrane protein–ligand binding
CD methods have been used qualitatively to identify and charac-
terise conformational changes in membrane proteins induced upon
ligand binding. Examples of studies investigating ligand-induced
changes on secondary structure and α-helical content, utilising thefar-UV region, include: the studies of Fuertes et al. (2001) on the
kinetoplastid membrane protein-11 of Leishmania infantum, in which
pH- and temperature-dependent Ca2+ binding, was revealed [34]; suc-
cessful application of CD techniques to immobilised proteinmembranes
to investigate changes in α-helical content in response to hormone
challenges [35]; and the studies of Dudzik et al. [36] on the neurological
α-synuclein protein implicated in Parkinson's disease, in which far-UV
CD spectroscopy was used to conﬁrm that there was no change in the
helicity of membrane-bound α-synuclein upon binding of its Cu2+ li-
gand [36]. Measurements in the visible regions involving time-
resolved CD spectroscopy have also been used; for example, this ap-
proach was used to verify the assembly kinetics of the light harvesting
chlorophyll a/b protein complex, in which it was shown that chloro-
phyll a binding possesses a fast kinetic phase whilst that of chlorophyll
bwas slower [37].
The ﬁrst quantitative data of membrane protein–ligand interac-
tions revealed through the use of SRCD spectroscopy was reported
during our studies of the intact membrane sensor kinase FsrC [24]
using Diamond beamline B23 [38,39]. FsrC belongs to the histidine
protein kinase family of predominantly membrane proteins that con-
stitute the sensory components of bacterial two-component signal
transduction systems. These systems are the main mechanism by
which bacteria sense and respond to environmental change [40,41].
FsrC is the sensory component of the Fsr signal transduction pathway
involved in quorum-driven gene regulation of several virulence factor
genes in the hospital-acquired infection agent Enterococcus faecalis
and other enterococci (Fig. 1) [42–44]. FsrC senses changes in cell
density or quorum by responding to changes in the external level of
the gelatinase biosynthesis-activating pheromone (GBAP), a small cy-
clic peptide of 11 amino acid residues: H3N+-QNSPNIFGQWM-COO−
(lactone-linked between Ser-3 and Met-11). Following interactions
between the GBAP ligand and the FsrC receptor, the pathway is acti-
vated through auto-phosphorylation of FsrC, followed by signal trans-
duction to FsrA and culminating in activation of virulence genes such
as gelatinase (GelE) and serine protease (SprE) and autoregulation of
the fsr genes (Fig. 1; [44]). Production of puriﬁed intact FsrC protein
that is active and responsive to the GBAP ligand was demonstrated
in a wide-ranging study designed to evaluate the overexpression
and puriﬁcation of the genome complement of intact membrane sen-
sor kinases of E. faecalis V583 [45]. In this study, the conditions re-
quired to successfully overexpress in Escherichia coli and to purify
intact FsrC (including its transmembrane and sensing domains)
were reported. Using in vitro activity assays, it was also shown that
full-length puriﬁed FsrC was isolated as an active protein and that it
responds to its GBAP signal in vitro, which is important information
for conﬁrming a link between conformational changes observed
using CD and changes in membrane enzyme activity [45].
The initial ligand–receptor interactions of quorum sensing sys-
tems such as Fsr are suggested to be promising targets for the design
of novel antibacterial drugs that might prove more effective against
antibiotic-resistant strains of bacteria [46]. To assess the feasibility
of novel drug design for disrupting GBAP–FsrC interactions, we
employed SRCD spectroscopy as a means for observing, investigating
and quantifying GBAP interactions with this detergent-solubilised
membrane protein. Several technical considerations were established
during these studies:
1) Reproducible SRCD spectra using beamline B23 [38,39] were
obtained only when a sufﬁcient incubation period was included
for FsrC stabilisation following sample dilution and preparation
from concentrated stocks [24]. For example, for FsrC in 0.02%
DDM repeated scan measurements in the far-UV region under
conditions that did not promote UV protein denaturation showed
signiﬁcant CD spectral changes that were used to determine the
amount of incubation time needed to measure reproducible CD
spectra. The incubation time required to equilibrate the structural
Fig. 1. The Fsr quorum (cell density) signal transduction pathway in Enterococcus faecalis (adapted from [44]). The ﬁrst step in signal transduction involves interactions between the
FsrC membrane sensor kinase (green) and the pheromone peptide GBAP (gelatinase biosynthesis-activating pheromone). GBAP is synthesised intracellularly and probably
transported externally by the FsrB transporter (blue). Upon GBAP binding, FsrC is autophosphorylated. This phosphorylation signal is transferred to FsrA, a response regulator
which is then able to signiﬁcantly upregulate several genes including GelE, SprE and other virulence associated factors.
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environment was determined to be 1.5 h prior to data collection
(Fig. 2A) [24]. A higher concentration of 0.05% DDM detergent
reduced the incubation period required. It is conceivable that the ef-
fect of DDM concentration observed for FsrC is related to the pro-
tein:detergent ratio established following protein dilution and that
this may occur as a general phenomenon amongst membrane pro-
teins. The ﬁnding here of a requirement for a concentration- and
time-dependent step for stabilisation of a puriﬁed membrane pro-
tein prior to SRCD measurements highlights the importance of de-
tergent considerations for ensuring protein stability, including
detergent and phospholipid types [30,47]. Indeed, the sensitivity of
SRCD spectroscopy revealed here for detecting instability may iden-
tify the technique as a valuable tool for screening of membrane pro-
tein preparations prior to downstream applications such as protein
crystallisation [48; see Chapter by de Moraes et al. in this Special
Issue] and NMR [49] in which protein stability is an important con-
sideration for success.
2) Titration experiments to obtain quantitative data included an in-
cubation period of 20 min following each addition of ligand prior
to obtaining spectral data.
3) Ten repeated scans and an integration time of 1 s were routinely
performed per sample during the FsrC ligand titration work. This
resulted in a good signal-to-noise ratio required for observing
small changes in the spectral intensity following incremental ad-
ditions of ligand. Thus, to acquire each spectrum, a total time of
75 min was required. For systems where the CD changes are
larger, fewer repeated scans are required because better signal-
to-noise ratio data can be acquired thereby reducing signiﬁcantly
the overall measurement times [7]. Other techniques such as sur-
face plasmon resonance (SPR) spectroscopy [50–52] requiring
sample immobilisation and often sample labelling, isothermal
titration calorimetry (ITC) [53,54], and ﬂuorescence resonance en-
ergy transfer (FRET) [55,56] requiring sample labelling, can also besuccessfully used to determine ligand binding but these tech-
niques reveal less information regarding molecular interactions
or direct conformational changes to the extent of CD and SRCD
spectroscopy. See other chapters on such techniques in this Spe-
cial Issue.
4) For small amounts of precious samples, appropriate small-volume
capacity cells of various pathlengths can be used to interrogate
different spectral regions that will convey information about
secondary structure folding and aromatic side-chains [57] of Phe,
Tyr, Trp and disulphide bonds [57] and prosthetic groups (heme,
NAD, FAD, cofactors [5]). For the vacuum UV region (170–250 nm)
very narrow cells (demountable or ﬁxed) of 0.05 to 0.1 mm
pathlength and 2–10 μl volume capacity can be used. In addition, it
is advantageous to utilise a very small and collimated light beam
that allows CD spectra to be measured through long pathlength
cells but with very small volume capacity (20–60 μl for a 1 cm cell,
350 μl for 5 cm and 700 μl for 10 cm) [38,39]. This can be an impor-
tant consideration when the amount of sample to be investigated is
very small, as was the case for FsrC discussed above [24].
It is important to note that the vacuum and far-UV region from
170 to 200 nm is the region of instrumental limitation for top-
bench CD instruments. This is often due to the combination of low
photon ﬂux as well as the high UV absorption of saline buffers. The
ability to penetrate that region using SRCD beamlines allows the anal-
ysis without artefacts of more spectral features, in particular those
associated with α-helix, β-turns and β-sheet conformations that oth-
erwise would not be possible. For measurements in aqueous solu-
tions, a reasonable cut-off limit should be 170 nm, which means
that any CD spectral feature observed below this should be rejected
as artefactual. Several such artefacts have been assigned to either
super secondary structures of proteins or to charge-transfer transi-
tions (reviewed in [38]). Longer pathlengths such as 1, 2, 5 and
10 cm of small diameter aperture with volume capacities of 30 to
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gand CD titrations at dilute concentrations without compromising the
overall CD intensity. These long pathlength cells can only be used
with a highly collimated SRCD-generated beam [38,39] but not with
the bench-top CD instruments because of their highly divergent
incident light beam. This is an important consideration when usingprecious and low abundance membrane protein samples, and can
make all the difference as to whether useful data can be obtained or
not.
Using stabilised puriﬁed FsrC and the technical considerations de-
scribed above, far- and near-UV SRCD spectra revealed that whilst
GBAP binding did not signiﬁcantly affect FsrC secondary structural
integrity, the local tertiary structure of the Tyr and Trp aromatic
side-chain residues was signiﬁcantly affected (Fig. 2B, C) [24]. CD ti-
tration experiments of GBAP into FsrC revealed a relatively loose
binding interaction of 1:1 stoichiometry, with a dissociation constant
kd of 2 μM calculated from CD data using a non-linear regression anal-
ysis [5–7]. These studies indicate a promising future for the use of
SRCD in quantifying ligand interactions and for identifying inhibitors
of FsrC–GBAP and membrane protein–ligand interactions more gen-
erally. Indeed, SRCD spectroscopy was recently used to study an in-
hibitor of FsrC activity, siamycin I [25]. Previous studies had already
shown that siamycin I inhibited gelatinase and GBAP production in
E. faecalis, suggestive of possible inhibition of a component of the
Fsr pathway [58]. Ma et al. [59] used puriﬁed intact FsrC in in vitro
phosphorylation assays to establish that FsrC was a direct target for
siamycin I inhibition. When FsrC–siamycin I interactions were inter-
rogated using SRCD spectroscopy, a signiﬁcant positive shift in the
near-UV spectrum was identiﬁed, especially in the 270–290 nm re-
gion of the Tyr and Trp aromatic side-chain residues (Fig. 3), with
only a very small change in secondary structure revealed in the
far-UV spectrum [25]. Siamycin I itself possesses one Tyr and one
Trp and therefore it is not possible to distinguish whether it is the
local tertiary structure of Tyr and Trp residues in the protein or in
the inhibitor that is affected upon binding. Nonetheless, the detection
of a discernible andmeasurable CD spectral change upon inhibitor bind-
ingmeans that further investigation of FsrC–siamycin I interactionswas
possible using SRCD spectroscopy. Moreover, this SRCD-based study
also revealed that no competition was observed between GBAP and
siamycin I upon binding to FsrC, as the CD spectrum of the FsrC–
GBAP–siamycin I mixture was the sum of the binary complex FsrC–
GBAP and FsrC–siamycin I (Fig. 3). The siamycin I inhibitor binding
site did not therefore overlap with the GBAP binding site.
In a study by Bettaney et al. [60], the SRCD spectra of three inositol
membrane transport proteins (IolF, IolT, YﬁG) measured with the Di-
amond B23 beamline showed a cut-off below 180 nm as indicated by
the voltage of the photomultiplier tube (PMT) detector exceeding
600 V (Fig. 4). It is essential that for accurate secondary structure es-
timations the positive CD bands at about 190–195 nm of theα-helical
conformation are measured with the lowest level of noise possible,
which can be readily achieved with synchrotron CD beamlines. Re-
peated scans can also improve the signal-to-noise-ratio but at in-
creased time (the noise is reduced by the root square of the number
of scans). Following successful conﬁrmation of secondary structural
integrity and composition, the speciﬁcity of these three proteins for
a large variety of inositols and sugars of D and L conﬁguration was de-
termined by measuring the cellular uptake of radiolabelled 3H-myo-
inositol in the presence of unlabelled competing compounds [60].Fig. 2. SRCD spectroscopic study of FsrC. A) Average of four far-UV SRCD spectra of pu-
riﬁed FsrC (6 μM) at 0 h (solid black line), 1.5 h (dashed line with unﬁlled square), and
2.5 h (dashed line with unﬁlled circle) following sample preparation in 10 mM sodium
phosphate pH 7.5 containing 0.02% DDM at 20 °C. Repeat spectra after 1.5 h involving
sample removal and reloading were also included (dashed line, with unﬁlled triangle)
(adapted from [24]; B) SRCD titration of GBAP binding to FsrC using near-UV SRCD
spectroscopy. The difference SRCD spectra of GBAP:FsrC at various molar ratios (0:1;
0.5:1; 1:1; 2:1; 3:1 and 5:1) were obtained by subtracting the spectra of GBAP at the
corresponding equivalent molar ratios (0.5; 1; 2; 3; 5) (adapted from [24]). C) Dissoci-
ation constant kd of GBAP:FsrC complex was calculated by ﬁtting the CD data at 277 nm
(solid circle) as a function of GBAP concentration using a non-linear regression analysis
method [5–7]. As both FsrC and GBAP possess CD features in the near-UV region, the
subtraction of the CD spectrum of GBAP from that of the GBAP:FsrC mixture reduces
the system from a two to one CD component allowing the ﬁtting to be of a Michael–
Menten saturation type (solid line) (adapted from [24]).
Fig. 3. Effect of GBAP on siamycin I binding to FsrC. Left) Far-UV region (185–260 nm) SRCD spectra of FsrC in 10 mM potassium phosphate, pH 7.5, containing 0.05% DDM (solid);
difference CD spectrum of {[(FsrC + siamycin I) (1:5)] − [(siamycin I) (0:5)]} (dash); difference CD spectrum of {[(FsrC + GBAP + siamycin I) (1:3:5)] − [(GBAP + siamycin I)
(0:3:5)]} (dot). In the case of FsrC alone, an equivalent volume of methanol used to dissolve siamycin I was also added to retain the same protein concentration in the mixtures with
ligands. Right) Near-UV region (250–340 nm) difference SRCD spectra of {[(FsrC (20 mM) + GBAP) (1:3)] − [(GBAP) (0:3)]} (solid), {[(FsrC + siamycin I) (1:5)] − [(siamycin I)
(0:5)]} (dash), and {[(FsrC + GBAP + siamycin I) (1:3:5)] − [(GBAP + siamycin I) (0:3:5)]} (dot) calculated by subtracting from the FsrC + ligand mixtures the SRCD spectra of
the ligands alone. Upon each addition of ligand or inhibitor, the mixtures were incubated for 20 min at 20 °C before conducting the SRCD measurements.
Both ﬁgures were adapted from [25].
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preference for binding carbohydrate ligands and sequence-based
programmes are used to predict such binding sites [61]. Since chiral car-
bohydrates lack near-UV chromophores, CD spectroscopy and in partic-
ular SRCD (for low available quantities of membrane proteins) provides
a powerful and sensitive means by which to study protein conforma-
tional changes upon carbohydrate ligand binding. Any interaction of
the inositol/sugar ligands of L and/or D conﬁguration with the Trp
amino acid residues of the inositol transporters would show changes
of the tryptophan CD like those illustrated in Fig. 5 for the CD titration
of hen white egg lysozyme with N,N,N triacetylchitotriose (NAG3).
CD measurements in the near-UV region of the spectrum are
clearly valuable for obtaining both qualitative and quantitative infor-
mation on membrane protein–ligand interactions. The wide range of
wavelengths that can be investigated using a collimated synchrotron
beamline that measures CD spectra from vacuum UV to far- andFig. 4. Far-UV SRCD studies of bacterial inositol membrane transporter proteins. SRCD spect
inositol transport membrane proteins. The insets are the plots of SRCD at 190 nm versus v
Adapted from [60]).near-UV and the visible spectral regions is made possible because
it operates a double grating monochromator with negligible stray
light (e.g. [38]).
Taking these data on ligand- and inhibitor-binding of a membrane
sensor kinase together, the suitability of beamline B23 for future
quantiﬁcation of drug- and ligand-binding to other membrane sensor
kinases, and indeed other membrane proteins more generally, is
established.
3. Identiﬁcation of functionally similar but mechanistically
distinct drugs
Although not an integral membrane protein, secretory phospholi-
pase A2 (PLA2) of snake venom is a membrane interfacial enzyme that
relies on tryptophan and other aromatic residues for interfacial bind-
ing to phosphatidylcholine and phosphatidylglycerol phospholipids, ara (solid line) and PMT response that is proportional to the absorption (dashed line) of
ariable temperature in the range 10° to 90° every 5 °C and back to 10 °C.
280
15
9
8
7
6
5
4
0 2 4 6
10
5
0
300
Wavelength (nm)
320
Fig. 5. CD spectra hen white lysozyme (Lyz) without and with N,N,N triacetylchitotriose
[(NAG)3] at various molar ratios (adapted from [5]). Top left inset) Plot of CD data at
294 nmversus (NAG)3 concentration. The titrationwas repeated at two different Lyz con-
centrations: 17.5 μM (red solid circle) and 445 μM (black solid circle). For the titration
with the higher Lyz concentration the (NAG)3 concentration is about 25.4 times bigger
than that reported for the lower Lyz in the plot axis. The datawere ﬁttedwith a non-linear
regression analysis [5–7] and for both titrations theﬁttingwas obtained for a kd=1.3 μM.
Top inset right) Rasmol cartoon of 1HEW PDB crystal structure of Lyz (grey) with (NAG)3
(red) interacting with three Trp residues (green).
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PLA2 lipolytic activity promotes the development of inﬂammatory pro-
cesses and therefore represents a valuable therapeutic target for anti-
inﬂammatory drugs such as the non-steroidal anti-inﬂammatory
drugs (NSAIDs). CD spectroscopy was recently used alongside ﬂuores-
cence measurements to study interactions between four NSAIDs
(meloxicam, lornoxicam, nimesulide and tenoxicam) and snake PLA2
[26]. The roles of the tryptophan and other aromatic residues were in-
vestigated using ﬂuorescence spectroscopy whilst the effects of NSAIDs
on enzyme secondary structural conformationwas studied using far-UV
CD measurements of PLA2 in the presence and absence of DMPC:DPPE
(7:3) liposomes.When PLA2was added to liposomes, theα-helical con-
tent increased from 34% in aqueous solution to 44% in the presence of
lipid membrane. The authors suggest that this change in α-helical con-
tent is consistentwith the role of theN-terminal amphipathicα-helix in
surface binding and in facilitating phospholipid entrance into the hy-
drophobic substrate-binding pocket, both of which require a ﬂexible
enzyme with dynamic properties [26,62,63]. Far-UV CDmeasurements
revealed that PLA2 secondary structural conformation changed little
upon addition of three of the NSAIDs (meloxicam, lornoxicam and
nimesulide) in the absence of liposomes. When these drugs were
added to the enzyme in the presence of liposomes, surprisingly there
was no increased α-helical content for PLA2; the α-helical content
remained at approximately 34% [26]. This ﬁnding not only conﬁrmed
that PLA2 is a target for these NSAID drugs, but also provided insight
into a possible mechanism of inhibition, suggesting that these threeNSAIDs may interact by affecting the ﬂexibility of structural α-helical
elements, reducing enzyme ﬂexibility and ability to be activated at the
interfacial surface of the membrane [26]. A fourth NSAID drug,
tenoxicam, which performs the same function as the other three
drugs through inhibition of PLA2 activity, was shown by CD measure-
ments to act through a different mechanism. Unlike the other three
NSAIDS, tenoxicam was able to induce signiﬁcant secondary structural
changes in the enzyme directly [26].
It is important to note that the four NSAID drugs are non-chiral mol-
ecules that contain aromatic chromophores (λ363 nm for meloxicam [64],
λ380 nm for lornoxicam [64], λ394 nm for nimesulide [65] and λ370 nm for
tenoxicam [64]). In Ref. [26], CD measurements in the 260–300 nm
near-UV region were not carried out otherwise they could have shown
overlapping contributions arising from the Tyr and Trp residues of PLA2
and the bound NSAIDs. However, only the bound species of NSAIDs
would have shown induced CD spectra in the 360–400 nm region as
the protein is devoid of any chromophore. This is, therefore, the ideal
spectral region to assess unambiguously and determine quantitatively
the binding stoichiometry and the dissociation constant kd of the PLA2–
NSAID complexes by CD spectroscopy [5–8] rather than ﬂuorescence
spectroscopy [26] that required the approximation of data correction
for the NSAID ligand re-absorption and inner ﬁlter effects. The CD ap-
proach could open up the possibility of further study to determine, for in-
stance, drug competition as described above for the FsrC example.
4. Effects of environment conditions (detergents/surfactants,
reducing agents, salt ionic strength and ligands) to observe
membrane protein–ligand interactions
As described above, the importance of considerations of detergent
environment for biophysical studies of membrane proteins has long
been recognised. Particular considerations of the appropriate micellar
environment to retain native protein folding, stability and activity
have been reported, for example, Corin et al. [28] screened several de-
tergents for their ability to produce and solubilise G-protein coupled
receptors (GPCR) expressed in cell-free systems. CD spectroscopy
was used to assess the folding of several puriﬁed GPCRs. In Fig. 8A,
the CD spectra of mOR103-15 protein produced with and without
Brij-35 showed the familiar high content of α-helical conformation
(≈50%) only with the detergent. Without detergent only 10% of the
protein was obtained showing mainly an irregular structure (Fig. 8A).
Kaiser et al. [29] reported the effects of increased NaCl salt concentra-
tion (50 mM) and the addition of reducing agent TCEP (1 mM) to the
buffer (25 mM Tris, 10% glycerol, 3 times the critical micelle concentra-
tion (cmc) of Fos-Choline 14 (FC14) and 150 mM NaCl) enhanced sub-
stantially the amount of α-helical content of E. coli free-cell GPCR
protein expressed in the presence of FC14 or Tri-mix detergents (Fig. 8B).
CD spectroscopy is the easier and faster technique to investigate
whether ligand binding promotes protein conformational changes.
O'Malley et al. [30] investigated the binding of several ligands,
determined by ﬂuorescence, revealing that no secondary structure
conformational changes were indeed promoted to the GPCR protein
hA2aR-His10 (Fig. 8C).
A CD- and NMR-based study of the TatCd membrane protein of the
twin arginine translocation (Tat) system of Bacillus subtilis tested the
effects of a range of different detergents on the secondary structure
content following reconstitution in detergent micelles and lipid vesi-
cles [31], whilst a SRCD spectroscopy study of cytolysin equinatoxin II
tested the effects of micellar and vesicle environments of different
lipid compositions on its pore forming function [32]. In addition, the
stabilising effect of a bilayer environment over a micellar environ-
ment was noted by Miles et al. (2011) during their studies on thermal
stability of two Na,K ATPases from different sources [33]. None of
those works included CD measurements conducted in the near UV
region characteristic of the local tertiary structure of the Phe, Tyr
and Trp aromatic side-chain amino acid residues as natural molecular
Fig. 6. Chemical formula of cetylpyridinium (CTP), cetrimide (CET), sodium dodecyl sulphate (SDS) and n-dodecyl β-D-maltoside (DDM).
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tion of the cell-free puriﬁed GPCR proteins was conﬁrmed using
microscale thermophoresis monitoring the changes of the Trp ﬂuo-
rescence of the protein as a function of carveol ligand. A CD titration
in the near UV region would have determined the binding stoichiom-
etry and the dissociation constant kd as well as opened the possibility
to investigate competition studies with other known ligands that
might necessitate inner-ﬁlter ﬂuorescence corrections hence intro-
ducing wider approximations to the data analysis. Similarly, for
O'Malley et al. [30], a ligand binding CD titration monitored in the
250–350 nm near UV region not only could have complemented the
ﬂuorescence quenching experiment but also could have opened the
study to ligand competition like that described in the FsrC workFig. 7. CD spectra in the far- and near-UV regions of SugE membrane protein with and witho
at 1:0 (solid line), 1:20 (dashed line) and 1:200 (dotted line) molar ratios. B) Near-UV CD sp
line) and 1:30 (light grey line) molar ratios. C) Far-UV CD spectra of 5 μM SugE in DDM (3.9
D) Near-UV CD spectra of 31 μM SugE in DDM (3.9 mM):CET at 1:0 (solid black line), 1:3 (
Figure adapted from [27].[25]. In general, the CD data acquisition should be conducted as far
as possible in both far- and near-UV regions for a better and complete
characterisation of the system. The examples described in this review
exemplify the exploitation of the near UV region CD data for screen-
ing and diagnostic purposes.
Another important example is the effects of detergent environment
on ligand binding by SugE recently investigated using CD spectroscopy
[27]. SugE is a member of the SMR protein family of secondary active
multidrug transporters found in bacteria and it binds antiseptic quater-
nary cation ligands (Fig. 6) such as cetylpyridinium (CTP) and cetrimide
(CET) thereby conferring host resistance to these compounds. Using
far-UV CD spectroscopy, SugE was shown to possess identical, high
α-helical content in two different detergents, sodium dodecyl sulphateut CTP and CET respectively. A) Far-UV CD spectra of 5 μM SugE in DDM (3.9 mM):CTP
ectra of 31 μM SugE in DDM (3.9 mM):CTP at 1:0 (solid black line), 1:3 (solid dark grey
mM):CET at 1:0 (solid line), 1:20 (dashed line), and 1: 200 (dotted line) molar ratios.
solid dark grey line) and 1:30 (light grey line) molar ratios.
Fig. 8. CD spectra of GPCR proteins. A) mOR103-15 protein made with (open circle) or
without (solid square) Brij-35 detergent (ﬁgure adapted from [28]); B) hOR17-4
protein in 25 mM Tris (pH 7), 10% glycerol, 3 × cmc Fos-Choline 14 (FC14) with
200 mM NaCl (black) or with 150 mM NaCl and 1 mM TCEP (grey) (ﬁgure adapted
from [29]); C) hA2aR-His10 protein without (black) and with CHA agonist (dashed),
theophylline (dotted) and 1 mM TCEP (dashed–dotted) ligands.
Figure adapted from [30].
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niﬁcant changes in the secondary structure content of the protein upon
addition of up to 200 fold CTP or CET in the presence of either SDS- or
DDM-solubilised protein (Fig. 7) [27]. By contrast, measurements in
the near-UV region revealed not only signiﬁcant differences in tertiary
structural arrangements depending on the detergent used, but also dif-
ferent effects of each ligand, though ligand effects were observable only
in the DDM micellar environment (Fig. 7). The different effects of the
two detergents are consistent with hydrophilic interactions betweenthe quaternary cationic moieties of CTP and CET ligands and the anionic
sulphate heads of SDS micelles, whereas the lack of such interactions
with the maltoside moiety of DDM did not preclude CTP and CET bind-
ing to the SugE membrane protein. Thus this elegant study not only
highlighted the importance of detergent choice but also provided fur-
ther evidence of the versatility of CD spectroscopy in ligand binding
studies using intact membrane proteins in micellar environments.
5. Summary
The work described in this chapter conﬁrms and highlights the
versatility of CD spectroscopy for studies of membrane proteins, par-
ticularly when a wide spectral range can be achieved for both protein
and chromophore, including determinations of secondary structural
integrity and composition, conﬁrmation and quantitation of ligand
binding, characterisation of (detergent) conditions suitable for ob-
serving ligand binding using stabilised protein, and identiﬁcation of
mechanistically distinct drugs that bring about the same function.
It is the amide bond of the protein backbone structure that gives in-
formation about protein secondary structure, and the aromatic
side-chains of Phe, Tyr and Trp residues about their local tertiary
structure. The chromophore of the ligand can be used to determine
unambiguously ligand binding in both far- and near-UV regions and
in particular whether protein conformational changes are occurring
upon ligand binding. This approach of achieving a complete CD spec-
troscopic study in solution for membrane proteins is clearly advanta-
geous. In particular SRCD provides the extension of the vacuum UV
region allowing measurements of far less transparent media and in
small volumes that are unattainable with bench-top CD instruments.
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